Seung Hyun Kim

This study uses CRISPR/Cas9 RNP to edit regulatory DNA elements in human islet cells, revealing their role in diabetes risk and β cell function.

The paper introduces a modular, open-source platform for interfacing with living neurons, enabling scalable and versatile recording and stimulation across various neural cultures and applications.

This study identifies plasma miRNA-214-3p as a biomarker predicting ALS progression speed by linking it to phagocytic dysfunction in patient-derived microglia.

This study corrects an ABCD1 mutation in ALD patient-derived iPSCs using CRISPR/Cas9 and homology-directed repair, restoring normal protein expression but not fully correcting metabolic issues.